FMC Corporation 10-Q Summary: Period Ended June 30, 2008
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2008, and the six months ended June 30, 2008. FMC Corporation is a diversified, global chemical company operating in three segments: Agricultural Products, Specialty Chemicals, and Industrial Chemicals. The company reported strong performance across all segments, driven by higher sales volumes, pricing, and productivity improvements, partially offset by rising raw material and energy costs.
Key Financial Metrics
| Metric (in Millions) | Three Months Ended 6/30/08 | Six Months Ended 6/30/08 | Six Months Ended 6/30/07 |
|---|---|---|---|
| Revenue | $806.6 | $1,556.8 | $1,332.0 |
| Net Income | $84.4 | $178.3 | $54.4 |
| Diluted EPS | $1.10 | $2.33 | $0.70 |
| Operating Cash Flow | N/A | $138.4 | $52.6 |
| Total Debt | $554.3 | $554.3 | $545.2 |
| Cash and Equivalents | $123.3 | $123.3 | $75.5 |
Margins: The filing does not explicitly state gross or operating margin percentages. However, Income from continuing operations before taxes was $134.7 million for the quarter and $277.2 million for the six months.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 22.6% for the quarter and 16.9% for the six months compared to the prior year, driven by growth in all three segments.
- Profitability Surge: Net income for the six months increased 228% ($178.3M vs. $54.4M). This was primarily due to higher segment operating profits and a significant reduction in restructuring charges compared to 2007.
- Restructuring Impact: Restructuring and other charges were $10.7 million for the quarter and a net gain of $2.4 million for the six months in 2008. This contrasts sharply with $92.7 million in charges for the quarter and $117.0 million for the six months in 2007. The 2007 figures were heavily impacted by a $75.2 million charge for the Baltimore facility phase-out and a $22.5 million Solutia legal settlement.
- Asset Sales: The 2008 results included a $29.6 million gain from the sale of the Princeton research center and a $3.6 million gain from the sale of sodium sulfate assets.
Guidance, Outlook, and Risks
Outlook:
- Agricultural Products: Full-year revenue growth expected in the mid-teens; operating profits expected to be up nearly 20%.
- Specialty Chemicals: Full-year revenue growth expected in the low teens; operating profits expected to be up 5-10%.
- Industrial Chemicals: Full-year revenue growth expected in the mid-teens; operating profits expected to approximately double.
Management Commentary: Management noted continued impacts from higher raw material and energy costs. The company announced an agreement to acquire the hydrocolloids ingredients business of International Specialty Products (ISP), expected to close in the second half of 2008.
Risks and Contingencies:
- Regulatory: Ongoing EPA review of carbofuran in the U.S. and EU deregistration of carbofuran, carbosulfan, and cadusafos. FMC is litigating the EU decisions and defending U.S. registrations.
- Legal: Pending antitrust litigation regarding hydrogen peroxide in the U.S. and Europe (including a €25.0 million fine from the European Commission, currently under appeal). Also pending are settlements related to microcrystalline cellulose antitrust claims.
- Environmental: Estimated reasonably possible environmental loss contingencies may exceed accrued amounts by approximately $75 million.
Investor Verification Checklist
- Verify the status of the EPA's final decision on carbofuran tolerances and the outcome of EU litigation regarding product deregistration.
- Monitor the progress of the hydrogen peroxide antitrust settlements and the European Commission appeal.
- Confirm the closing date and integration progress of the International Specialty Products (ISP) hydrocolloids acquisition.
- Review the impact of rising raw material and energy costs on future margin compression, despite volume and price increases.
- Assess the company's ability to maintain liquidity given projected environmental spending of approximately $34 million for remediation and $26-27 million for compliance in 2008.